Posted: 15 June 2023 Telix Pharmaceuticals has topped the inaugural Financial Review Fast Global list, with international revenue growth at the Melbourne-based, cancer-fighting biotech soaring off the back of a drug approval in the US. The Fast Global…
Posted: 13 June 2023 Telix today welcomes Willy Borsus, Vice-President of Wallonia, Minister of Economy, Research and Innovation, Digital, Agriculture, Urban Planning and Regional Planning to officially open Telix Manufacturing Solutions, the Company’s radiopharmaceutical production facility located in…
Posted: 13 June 2023 Today, in the presence of Australia’s Prime Minister, the Honourable Anthony Albanese MP, RMIT University announced the next phase of its Country Commitment to Vietnam, including a AUD $250 million strategic investment fund. The…
Posted: 13 June 2023 Breakthrough Victoria is investing $10 million towards a new world-leading eye clinical trials centre that will provide Victorians with early access to new treatments aiming to prevent and cure blindness. The new eye clinical…
Posted: 9 June 2023 ARCS Australia has released a white paper to define common terms used in decentralised clinical trials providing a common and consistent language for the sector. The paper was released on day two of the…
Posted: 9 June 2023 Kinoxis Therapeutics is pleased to announce it has been awarded a UH3 grant by the National Institute on Drug Abuse (NIDA), part of the US National Institutes of Health (NIH), which is expected to…
Posted: 9 June 2023 Australia’s national science agency, CSIRO, has invested $25 million up to 2027 in a new program that will harness the building blocks of life to solve intractable problems. Advanced Engineering Biology (AEB) is the latest…
Posted: 9 June 2023 Avecho Biotechnology Limited today announced it has completed the development of first generation TPM® gummies containing cannabinoids. TPM cannabinoid gummies out–perform standard products with faster onset and greater magnitude of effect.Gummies are chewable, jelly–like preparations made…
Posted: 9 June 2023 ASX-listed Optiscan Imaging is ramping up its bid to pioneer a new standard of care in digital pathology and precision surgery, with its biopsy-free, slide-free, non-invasive, live single-cell medical imaging technology. The company’s patented…
Posted: 7 June 2023 Transformative cancer diagnostics technology company Rhythm Biosciences Ltd (ASX: RHY) (Rhythm or the Company) is pleased to announce that the abstract detailing the main results from the clinical trial for ColoSTAT®, its simple blood…
Posted: 6 June 2023 Starpharma today announces that it has achieved regulatory approval for its antiviral nasal spray product, VIRALEZE™, in Malaysia. The registration will allow Starpharma and its commercial partners to market and sell the product in Malaysia,…
Posted: 5 June 2023 The science of this game-changing Monash-led research is complicated. But also, in the end, pretty simple. The shape of your brain is much more important than scientists have previously thought, learning now that how…